Global Cryotherapy Ablation Device Market Strategic Research Report

Scope of the Report

The global Cryotherapy Ablation Device market size is predicted to grow from US$ 545 million in 2025 to US$ 2,529 million in 2032; it is expected to grow at a CAGR of 24.8% from 2026 to 2032.

Cryoablation is a procedure that uses extremely cold gas to freeze and destroy abnormal cells or diseased tissue. It's often used for skin disorders and cancer. Also called cryotherapy or cryosurgery, the procedure is usually safer and less invasive than surgery to cut out diseased tissue.

Boston Scientific and Siemens are the top two manufacturers of cryotherapy ablation device globally and account for over 70% of global market share in total. Geographically speaking, North America holds about 30% of global market share, followed by Europe with about 25% share. In terms of type, joule-thomson throttling refrigeration segment holds an important share of about 80%. In terms of application, prostate cancer holds over 25% of total market share.

Cryotherapy ablation device is a medical device used to treat cancer and arrhythmias that uses extremely cold fluids (such as liquid nitrogen, argon, nitrous oxide, or carbon dioxide) to freeze and destroy abnormal cells or diseased tissue. The cryotherapy ablation device market is expected to continue to grow as the prevalence of cancer and arrhythmias, the demand for minimally invasive surgery, the advantages of cryoablation technology are more widely recognized, and physicians adopt cryoablation devices more.

In terms of technology, cryotherapy ablation device can be divided into two types: phase change cooling and Joule-Thomson throttling cooling. Application areas include kidney cancer, lung cancer, prostate cancer, liver cancer, breast cancer, etc. Major players in the market include companies such as Icecure Medical, Boston Scientific, Metrum Cryoflex, Siemens, Hygea Beijing, AccuTarget MediPharma, and Sanarus Medical.

Overall, the cryotherapy ablation device market benefits from technological advancements, an aging population, an increase in the demand for minimally invasive surgery, and a rising prevalence of cancer and arrhythmias. With the continuous advancement of technology and the continuous development of the market, the cryotherapy ablation device industry is expected to achieve more efficient and safer treatment methods.

This report presents a comprehensive overview of the global Cryotherapy Ablation Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Phase Change Refrigeration
• Joule-Thomson Throttling Refrigeration

Segment by Application

• Pharmacy
• Kidney Cancer
• Lung Cancer
• Prostate Cancer
• Liver Cancer
• Breast Cancer
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cryotherapy Ablation Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmacy, Kidney Cancer, Lung Cancer evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact